SAGE
SAGE Therapeutics Inc
Price:  
22.55 
USD
Volume:  
1,010,714.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE Relative Valuation

-1183.9%
Upside

As of 2024-02-29, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (244.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.55 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1183.9%.

The range of the Relative Valuation is (248.20) - (241.71) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 27.5x - 29.3x 27.7x
Forward P/E multiples 26.0x - 26.8x 26.5x
Fair Price (248.20) - (241.71) (244.41)
Upside -1200.7% - -1171.9% -1183.9%
22.55 USD
Stock Price
(244.41) USD
Fair Price

SAGE Relative Valuation - Historical P/E Data

Date P/E
2024-02-28 -2.50
2024-02-27 -2.52
2024-02-26 -2.51
2024-02-23 -2.44
2024-02-22 -2.47
2024-02-21 -2.46
2024-02-20 -2.46
2024-02-16 -2.58
2024-02-15 -2.82
2024-02-14 -2.86
2024-02-13 -2.55
2024-02-12 -2.64
2024-02-09 -2.63
2024-02-08 -2.64
2024-02-07 -2.65
2024-02-06 -2.74
2024-02-05 -2.69
2024-02-02 -2.75
2024-02-01 -2.88
2024-01-31 -2.84
2024-01-30 -2.87
2024-01-29 -2.94
2024-01-26 -2.92
2024-01-25 -2.91
2024-01-24 -2.94
2024-01-23 -2.96
2024-01-22 -2.91
2024-01-19 -2.88
2024-01-18 -2.89
2024-01-17 -2.99
2024-01-16 -2.93
2024-01-12 -2.94
2024-01-11 -2.98
2024-01-10 -2.82
2024-01-09 -2.92
2024-01-08 -2.78
2024-01-05 -2.38
2024-01-04 -2.34
2024-01-03 -2.40
2024-01-02 -2.49
2023-12-29 -2.40
2023-12-28 -2.45
2023-12-27 -2.47
2023-12-26 -2.46
2023-12-22 -2.42
2023-12-21 -2.38
2023-12-20 -2.32
2023-12-19 -2.46
2023-12-18 -2.35
2023-12-15 -2.40